Literature DB >> 1322182

Cytomegalovirus and marrow function.

B Torok-Storb1, P Simmons, D Khaira, D Stachel, D Myerson.   

Abstract

Infection with cytomegalovirus (CMV) continues to be one of the most common complications following allogeneic bone marrow transplantation. A proportion of patients with CMV infection also experience neutropenia. To investigate the possible role of CMV in the suppression of hematopoiesis, we have examined the effect of CMV on the growth of isolated myeloid progenitors and on the production of myeloid cells in the long-term bone marrow culture (LTMC) system. In these studies, various isolates of CMV were added either directly to cultures of progenitors or to LTMC established from normal CMV-seronegative donors. In the first system, myelosuppression is manifested by a reduction in the number of colonies that grow. In the second system, myelosuppression is manifested by a reduction in the number of myeloid cells produced and released into the culture supernatant. Analysis of the data observed indicated that myelosuppression could in some cases be attributed to direct infection of myeloid progenitors. In other cases stromal cells were infected. In the latter cases, myelosuppression was then caused by an alteration in cytokines produced by the stromal cells. These observations made in vitro raise the possibility that comparable mechanisms may be responsible for the myelosuppression observed with CMV infection in vivo. To pursue this possibility we proposed to detect the CMV genome in defined subpopulations of marrow cells isolated from infected patients. Given the technical restrictions imposed by the small sample size available from patient marrow aspirations, our initial attempts to develop on appropriate technique involved isolation of cells from CMV-seropositive normal bone marrow donors. Using the polymerase chain reaction we were able to amplify CMV DNA contained within marrow cells of some healthy CMV-seropositive marrow donors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322182     DOI: 10.1007/bf01715365

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  16 in total

1.  Producing single-stranded DNA probes with the Taq DNA polymerase: a high yield protocol.

Authors:  U Finckh; P A Lingenfelter; D Myerson
Journal:  Biotechniques       Date:  1991-01       Impact factor: 1.993

2.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Infection of bone marrow cells by hepatitis B virus.

Authors:  J L Romet-Lemonne; E Elfassi; W Haseltine; M Essex
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

4.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

Authors:  G V Quinnan; N Kirmani; A H Rook; J F Manischewitz; L Jackson; G Moreschi; G W Santos; R Saral; W H Burns
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

5.  Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance.

Authors:  R W Schroff; R P Gale; J L Fahey
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

6.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

Review 7.  Cytomegalovirus infections after allogeneic bone marrow transplantation.

Authors:  D J Winston; W G Ho; R E Champlin
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

8.  Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.

Authors:  R Storb; R L Prentice; E D Thomas; F R Appelbaum; H J Deeg; K Doney; A Fefer; B W Goodell; E Mickelson; P Stewart
Journal:  Br J Haematol       Date:  1983-12       Impact factor: 6.998

9.  Host origin of marrow stromal cells following allogeneic bone marrow transplantation.

Authors:  P J Simmons; D Przepiorka; E D Thomas; B Torok-Storb
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

10.  Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1.

Authors:  R M Stenberg; P R Witte; M F Stinski
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

View more
  9 in total

1.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

2.  Human cytomegalovirus inhibits cytokine-induced macrophage differentiation.

Authors:  Sara Gredmark; Tamara Tilburgs; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus.

Authors:  A Raza
Journal:  Med Oncol       Date:  1998-09       Impact factor: 3.064

4.  Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34+ Hematopoietic Progenitor Cells.

Authors:  Meaghan H Hancock; Lindsey B Crawford; Andrew H Pham; Jennifer Mitchell; Hillary M Struthers; Andrew D Yurochko; Patrizia Caposio; Jay A Nelson
Journal:  Cell Host Microbe       Date:  2019-12-19       Impact factor: 21.023

5.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

6.  Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation.

Authors:  Lindsey B Crawford; Nicole L Diggins; Patrizia Caposio; Meaghan H Hancock
Journal:  mBio       Date:  2022-01-11       Impact factor: 7.867

Review 7.  microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells.

Authors:  Mengyao Yu; Yuexinzi Jin; Shichang Zhang; Jian Xu; Jiexin Zhang
Journal:  Vaccines (Basel)       Date:  2022-01-19

8.  CD34+ Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.

Authors:  Lindsey B Crawford; Meaghan H Hancock; Hillary M Struthers; Daniel N Streblow; Andrew D Yurochko; Patrizia Caposio; Felicia D Goodrum; Jay A Nelson
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

9.  Human Cytomegalovirus Infection Suppresses CD34+ Progenitor Cell Engraftment in Humanized Mice.

Authors:  Lindsey B Crawford; Rebecca Tempel; Daniel N Streblow; Andrew D Yurochko; Felicia D Goodrum; Jay A Nelson; Patrizia Caposio
Journal:  Microorganisms       Date:  2020-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.